Results 161 to 170 of about 817,572 (203)

Seronegative End-Stage Type I Achalasia With Megaesophagus in a Middle-Aged Woman From Central America: A Case Report. [PDF]

Cureus
Dominguez DC, Richard J, El-Talla A.
europepmc   +1 more source

Developing Botulinum Toxin Drugs: Unexpected Challenges. [PDF]

J Neural Transm (Vienna)
Dressler D, Frevert J.
europepmc   +1 more source

Whole-genome analysis and phenotypic antimicrobial resistance of <i>Staphylococcus aureus</i> isolated from foods in Northern Kazakhstan. [PDF]

Front Microbiol
Kozhakhmetova SS, Zholdybayeva EV, Basharova DA, Bekbayeva A, Toleuzhanova AB, Daniyarov AZ, Bulashev AK.   +6 more
europepmc   +1 more source

Botulinum Toxin Injection to Treat Bruxism in a Child: A Case Report and Technique Description. [PDF]

Cureus
Mallaguti FI, Malaguti JG, de Paula Rodrigues Júnior O.   +2 more
europepmc   +1 more source

The Clinical, Genetic, Psychosocial, and Care Landscape of X-Linked Dystonia-Parkinsonism in Filipino Men: A Scoping Review. [PDF]

Am J Mens Health
Ramos MD, Manning J, Harris J, Adorno M, Marye R, Evangelista L.   +5 more
europepmc   +1 more source

Characterization of a novel family of AB toxins with potential to be used as antigen delivery vehicles

openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Bacterial AB toxins and host–microbe interactions

2022
AB toxins are protein virulence factors secreted by many bacterial pathogens, contributing to the pathogenicity of the cognate bacteria. AB toxins consist of two functionally distinct components: the enzymatic "A" component for pathogenicity and the receptor-binding "B" component for toxin delivery.
openaire   +2 more sources

AB5 toxins: structures and inhibitor design

Current Opinion in Structural Biology, 2000
High-resolution crystal structures of AB(5) toxins in their native form or in complex with a variety of ligands have led to the structure-based design and discovery of inhibitors targeting different areas of the toxins. The most significant progress is the development of highly potent multivalent ligands that block binding of the toxins to their ...
E, Fan, E A, Merritt, C L, Verlinde, W G, Hol   +3 more
openaire   +2 more sources